Osimertinib as Neoadjuvant Therapy for Resectable Non-Small Cell Lung Cancer: A Case Series

• Main Authors: Yan Hu (Author), Siying Ren (Author), Lulu Yang (Author), Zhongyi Tong (Author), Ruoyao Wang (Author), Wei Han (Author), Chao Zeng (Author), Jina Li (Author), Peng Xiao (Author), Li Wang (Author), Fenglei Yu (Author), Wenliang Liu (Author)
• Format: Book
• Published: Frontiers Media S.A., 2022-04-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Background: Evidence of osimertinib as neoadjuvant therapy for resectable non-small cell lung cancer (NSCLC) are currently lacking. This case series study aimed to assess the safety and feasibility of neoadjuvant osimertinib therapy followed by surgery for resectable NSCLC.Materials and methods: Pat...